Advanced

Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply

Lakkakorpi, PT; Vaananen, HK and Härkönen, Pirkko LU (2004) In Cancer Research 64(8). p.2935-2936
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Cancer Research
volume
64
issue
8
pages
2935 - 2936
publisher
American Association for Cancer Research Inc.
external identifiers
  • wos:000220810400045
ISSN
1538-7445
language
English
LU publication?
yes
id
726b8ea6-4022-40d9-89b1-e2f754acf645 (old id 281052)
alternative location
http://cancerres.aacrjournals.org/cgi/content/full/64/8/2934
date added to LUP
2007-10-24 07:52:37
date last changed
2016-04-16 03:45:06
@article{726b8ea6-4022-40d9-89b1-e2f754acf645,
  author       = {Lakkakorpi, PT and Vaananen, HK and Härkönen, Pirkko},
  issn         = {1538-7445},
  language     = {eng},
  number       = {8},
  pages        = {2935--2936},
  publisher    = {American Association for Cancer Research Inc.},
  series       = {Cancer Research},
  title        = {Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply},
  volume       = {64},
  year         = {2004},
}